LivaNova PLCNASDAQ:LIVN
- LAST PRICE53.1445
- TODAY'S CHANGE (%)0.3745 (0.7097%)
- Bid / Lots53.1300/ 16
- Ask / Lots53.2300/ 16
- Open / Previous Close52.7300 / 52.7700
- Day Range
- 52 Week Range
- Volume69,417
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LIVN |
|---|---|---|
| 09:32 ET | 1276 | 52.66 |
| 09:45 ET | 100 | 52.73 |
| 09:48 ET | 200 | 52.73 |
| 09:52 ET | 100 | 52.705 |
| 09:57 ET | 1144 | 52.54 |
| 09:59 ET | 1100 | 52.49 |
| 10:01 ET | 100 | 52.63 |
| 10:03 ET | 500 | 52.59 |
| 10:06 ET | 100 | 52.635 |
| 10:12 ET | 200 | 52.6 |
| 10:15 ET | 300 | 52.595 |
| 10:19 ET | 200 | 52.615 |
| 10:21 ET | 748 | 52.68 |
| 10:24 ET | 700 | 52.785 |
| 10:26 ET | 1100 | 52.715 |
| 10:28 ET | 300 | 52.72 |
| 10:30 ET | 100 | 52.8 |
| 10:32 ET | 1495 | 52.935 |
| 10:33 ET | 700 | 52.95 |
| 10:35 ET | 120 | 52.93 |
| 10:37 ET | 800 | 53 |
| 10:39 ET | 300 | 52.97 |
| 10:42 ET | 4800 | 53.12 |
| 10:44 ET | 500 | 53.2 |
| 10:48 ET | 100 | 53.295 |
| 10:51 ET | 12883 | 53.17 |
| 10:57 ET | 100 | 53.21 |
| 11:00 ET | 100 | 53.16 |
| 11:06 ET | 798 | 53.045 |
| 11:13 ET | 100 | 53.07 |
| 11:22 ET | 623 | 53.09 |
| 11:26 ET | 278 | 53.086 |
| 11:27 ET | 400 | 53.34 |
| 11:29 ET | 5881 | 53.39 |
| 11:33 ET | 500 | 53.26 |
| 11:36 ET | 400 | 53.21 |
| 11:38 ET | 171 | 53.216 |
| 11:40 ET | 386 | 53.17 |
| 11:44 ET | 100 | 53.025 |
| 11:47 ET | 100 | 53.015 |
| 11:49 ET | 500 | 52.98 |
| 11:51 ET | 100 | 52.98 |
| 12:00 ET | 500 | 53.11 |
| 12:14 ET | 1158 | 53.1 |
| 12:18 ET | 300 | 53.22 |
| 12:27 ET | 700 | 53.245 |
| 12:34 ET | 646 | 53.1445 |
Oct 8, 2024
LivaNova Appoints Susan Podlogar as a New Director, from 9:00AM ET on Tuesday Oct 08, 2024 by Dow Jones
9:00AM ET on Tuesday Oct 08, 2024 by Dow Jones
Oct 4, 2024
DJ LivaNova Initiated at Buy by Goldman Sachs, from 7:54AM ET on Friday Oct 04, 2024 by Dow Jones
7:54AM ET on Friday Oct 04, 2024 by Dow Jones
Sep 25, 2024
Press Release: LivaNova to Announce Third-Quarter 2024 Results, from 9:04AM ET on Wednesday Sep 25, 2024 by Dow Jones
9:04AM ET on Wednesday Sep 25, 2024 by Dow JonesLivaNova to Announce Third-Quarter 2024 Results, from 9:00AM ET on Wednesday Sep 25, 2024 by Dow Jones
9:00AM ET on Wednesday Sep 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
LivaNova PLC | 2.9B | -169.6x | --- |
Neogen Corp | 3.0B | -128.7x | --- |
Guardant Health Inc | 2.6B | -5.0x | --- |
Conmed Corp | 2.0B | 20.1x | +8.12% |
Inari Medical Inc | 2.6B | -45.1x | --- |
Tandem Diabetes Care Inc | 2.2B | -16.0x | --- |
Company Information
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related accessories. It includes the Essenz Perfusion System, the Company’s next-generation HLM with an embedded patient monitor for tailored patient care strategies. Neuromodulation segment is engaged in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). The ACS segment is engaged in the development, production, and sale of temporary life support products.
Contact Information
- Headquarters
- 20 Eastbourne TerraceLONDON, United Kingdom W2 6LG
- Phone
- 203-325-0662
- Fax
- ---
Executives
- Independent Chairman of the Board
- William Kozy
- Chief Executive Officer, Director
- Vladimir Makatsaria
- Chief Financial Officer
- Alex Shvartsburg
- President, Global Epilepsy
- Stephanie Bolton
- Senior Vice President, Chief Legal Officer, Corporate Secretary
- Michael Hutchinson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.9B |
|---|---|
Revenue (TTM) | $1.2B |
Shares Outstanding | 54.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.01 |
EPS | $-0.31 |
Book Value | $23.70 |
P/E Ratio | -169.6x |
Price/Sales (TTM) | 2.4 |
Price/Cash Flow (TTM) | 95.5x |
Operating Margin | -4.82% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
